Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
40.89
-0.56 (-1.35%)
May 20, 2026, 11:29 AM CST

SHA:600211 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,8282,3271,6481,8601,140764.41
Trading Asset Securities
995.321,123976.62515.34792.49537.87
Cash & Short-Term Investments
3,8233,4502,6252,3751,9321,302
Cash Growth
22.28%31.44%10.51%22.92%48.38%66.22%
Accounts Receivable
703.69917.49732.82856.71625.68632.32
Other Receivables
18.3117.4411.8511.8212.6312.83
Receivables
722934.93744.67868.52638.31645.15
Inventory
193.31181.27134.19111.4399.95137.32
Prepaid Expenses
-0.070.310.011.5-
Other Current Assets
57.470.8965.9147.7740.0497.16
Total Current Assets
4,7964,6373,5703,4032,7122,182
Property, Plant & Equipment
642.01655.35669.85600.33551.38764.54
Long-Term Investments
409.1425.5132.94116.62129.75130.25
Goodwill
82.8484.018.888.888.888.88
Other Intangible Assets
287.48300.78184.09202.46416.48411.66
Long-Term Deferred Tax Assets
129.93132.52151.05115.4871.3467.16
Long-Term Deferred Charges
5.275.622.631.932.7947.69
Other Long-Term Assets
39.4526.327.99138.79206.96190.57
Total Assets
6,3926,2674,7474,5874,1003,803
Accounts Payable
30.6831.913.55.5114.3713.22
Accrued Expenses
83.72587.08377.65530.39412.7398.67
Short-Term Debt
1,050840.34272.17499.99486.1534.66
Current Portion of Leases
-0.850.920.8812.13
Current Income Taxes Payable
-29.0325.545.3127.1322.13
Current Unearned Revenue
6.132.954.919.845.343.29
Other Current Liabilities
491.82147.9771.9292.5679.56135.56
Total Current Liabilities
1,6631,640766.571,1841,0261,110
Long-Term Debt
10-----
Long-Term Leases
0.140.150.31.131.141.86
Long-Term Unearned Revenue
27.5728.1127.3625.8527.5330.5
Long-Term Deferred Tax Liabilities
25.1725.4612.2914.0115.61
Other Long-Term Liabilities
438.47436.06----
Total Liabilities
2,1642,130795.231,2141,0691,158
Common Stock
322.32322.32322.32247.94247.94247.94
Additional Paid-In Capital
744.75752.21,1881,2631,2661,265
Retained Earnings
2,9632,6642,3301,7731,4551,169
Comprehensive Income & Other
47.4459.5177.5761.2142.98-51.42
Total Common Equity
3,9003,7983,9183,3453,0122,630
Minority Interest
327.76339.0534.2929.0319.0314.66
Shareholders' Equity
4,2284,1373,9523,3743,0312,645
Total Liabilities & Equity
6,3926,2674,7474,5874,1003,803
Total Debt
1,060841.34273.39501.99488.25538.65
Net Cash (Debt)
2,7632,6092,3511,8731,444763.63
Net Cash Growth
5.88%10.95%25.54%29.71%89.11%-1.22%
Net Cash Per Share
8.578.097.295.804.482.36
Filing Date Shares Outstanding
321.19322.32322.32322.32322.32322.32
Total Common Shares Outstanding
321.19322.32322.32322.32322.32322.32
Working Capital
3,1332,9972,8032,2181,6861,072
Book Value Per Share
12.1411.7812.1610.389.348.16
Tangible Book Value
3,5303,4143,7253,1332,5862,210
Tangible Book Value Per Share
10.9910.5911.569.728.026.86
Buildings
-535.52530.79462.4389.99439.89
Machinery
-309.36279.08446.34139.22159.08
Construction In Progress
-39.5365.0660.71153.6272.13
Source: S&P Global Market Intelligence. Standard template. Financial Sources.